These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19220820)

  • 21. Rapid encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Golla S; Horkan C; Dogaru G; Teske TE; Christopher K
    Acta Haematol; 2008; 120(2):100-3. PubMed ID: 18957844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients.
    Scaradavou A; Woo B; Woloski BM; Cunningham-Rundles S; Ettinger LJ; Aledort LM; Bussel JB
    Blood; 1997 Apr; 89(8):2689-700. PubMed ID: 9108386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemolysis after intravenous immune globulin therapy: relation to IgG subclasses of red cell antibody.
    Okubo S; Ishida T; Yasunaga K
    Transfusion; 1990 Jun; 30(5):436-8. PubMed ID: 2360236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Christopher K; Horkan C; Barb IT; Arbelaez C; Hodgdon TA; Yodice PC
    Am J Hematol; 2004 Nov; 77(3):299-302. PubMed ID: 15495245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Immune complex' mediated intravascular hemolysis due to IgM cephalosporin-dependent antibody.
    Salama A; Göttsche B; Schleiffer T; Mueller-Eckhardt C
    Transfusion; 1987; 27(6):460-3. PubMed ID: 3500531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemolytic anemia blunts the cytokine response to transfusion of older red blood cells in mice and dogs.
    Callan MB; Thawley VJ; Marryott KA; Shabro A; Fernando S; Kahn S; Hudson KE; Hod EA
    Transfusion; 2021 Dec; 61(12):3309-3319. PubMed ID: 34633666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in anti-D immune globulin for childhood immune thrombocytopenia: usage, response rates, and adverse effects.
    Long M; Kalish LA; Neufeld EJ; Grace RF
    Am J Hematol; 2012 Mar; 87(3):315-7. PubMed ID: 22190130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rho (D) immune globulin i.v. for prevention of Rh isoimmunization and for treatment of ITP.
    Med Lett Drugs Ther; 1996 Jan; 38(966):6-8. PubMed ID: 8544794
    [No Abstract]   [Full Text] [Related]  

  • 30. RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME).
    Despotovic JM; Lambert MP; Herman JH; Gernsheimer TB; McCrae KR; Tarantino MD; Bussel JB
    Transfusion; 2012 May; 52(5):1126-36; quiz 1125. PubMed ID: 21981825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis and mechanisms of antibody-mediated hemolysis.
    Flegel WA
    Transfusion; 2015 Jul; 55 Suppl 2(0):S47-58. PubMed ID: 26174897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe hemolytic anemia post-renal transplantation produced by donor anti-D passenger lymphocytes: case report and literature review.
    Ainsworth CD; Crowther MA; Treleaven D; Evanovitch D; Webert KE; Blajchman MA
    Transfus Med Rev; 2009 Apr; 23(2):155-9. PubMed ID: 19304116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia.
    Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E
    Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune hemolysis-serological and clinical aspects.
    Pruss A; Salama A; Ahrens N; Hansen A; Kiesewetter H; Koscielny J; Dörner T
    Clin Exp Med; 2003 Sep; 3(2):55-64. PubMed ID: 14598182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posttransplant immune-mediated hemolysis.
    Sokol RJ; Stamps R; Booker DJ; Scott FM; Laidlaw ST; Vandenberghe EA; Barker HF
    Transfusion; 2002 Feb; 42(2):198-204. PubMed ID: 11896335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute renal failure in a child with thrombocytopenic purpura caused by acute Epstein-Barr virus infection after treatment with anti-D immunoglobulin.
    Kossiva L; Kyriakou D; Mitsioni A; Garoufi A
    Pediatr Emerg Care; 2013 Jun; 29(6):748-50. PubMed ID: 23736070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti-D.
    Godeau B; Oksenhendler E; Brossard Y; Bartholeyns J; Leaute JB; Duedari N; Schaeffer A; Bierling P
    Transfusion; 1996 Apr; 36(4):328-30. PubMed ID: 8623133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passenger lymphocyte syndrome with or without immune hemolytic anemia in all Rh-positive recipients of lungs from rhesus alloimmunized donors: three new cases and a review of the literature.
    Cserti-Gazdewich CM; Waddell TK; Singer LG; Chaparro C; Pendergrast JM; Hawes J; denHollander N; Tinckam K; Keshavjee S
    Transfus Med Rev; 2009 Apr; 23(2):134-45. PubMed ID: 19304114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
    Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N
    J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.